radioactive iodine-131 (I-131) ablation

From Aaushi
Jump to navigation Jump to search

Indications

Contraindications

Procedure

Complications

* typical treatment dose is 200-300 megabecquerels

Management

* thyroid follicular cells, the origin of papillary thyroid carcinoma & follicular thyroid carcinoma, are TSH-responsive[1]

More general terms

References

  1. 1.0 1.1 1.2 Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 19 American College of Physicians, Philadelphia 2012, 2015, 2022
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  2. 2.0 2.1 2.2 Shim SR, Kitahara CM, Cha ES et al. Cancer risk after radioactive iodine treatment for hyperthyroidism: A systematic review and meta-analysis. JAMA Netw Open 2021 Sep 17; 4:e2125072. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34533571 Free article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2784269